Filing Details

Accession Number:
0001415889-23-013116
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-08 16:02:43
Reporting Period:
2023-09-06
Accepted Time:
2023-09-08 16:02:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070081 Ptc Therapeutics Inc. PTCT Pharmaceutical Preparations (2834) 043416587
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1918147 Alethia Young C/O Ptc Therapeutics, Inc.
100 Corporate Court
South Plainfield NJ 07080
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-09-06 7,000 $27.85 16,067 No 4 M Direct
Common Stock Disposition 2023-09-06 7,000 $39.90 9,067 No 4 S Direct
Common Stock Acquisiton 2023-09-06 4,666 $27.85 13,733 No 4 M Direct
Common Stock Disposition 2023-09-06 4,666 $39.79 9,067 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2023-09-06 7,000 $27.85 7,000 $27.85
Common Stock Stock Option (Right to Buy) Disposition 2023-09-06 4,666 $27.85 4,666 $27.85
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2032-06-08 No 4 M Direct
7,334 2032-06-08 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to Buy) $39.42 2033-01-04 10,000 10,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2033-01-04 10,000 10,000 Direct
Footnotes
  1. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $39.77 to $39.88 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  2. Currently exercisable.
  3. This option was granted on June 9, 2022 and vests over thirty-six approximately equal monthly installments, commencing on July 8, 2022
  4. This option was granted on January 5, 2023 and vests over one year in twelve equal monthly installments, commencing on February 5, 2023.